Medicare Enrolled
Dr. Daniel Kohane, M.D.
Interventional Pain Medicine Physician · Babylon, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kohane from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kohane?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kohane
Dr. Daniel Kohane is an interventional pain medicine physician in Babylon, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kohane performed 6,640 Medicare services across 1,754 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kohane received a total of $18,656 from 72 pharmaceutical and/or device companies across 1298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kohane is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 22% volume in NY
$18,656 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,640
Medicare services
Top 22% in NY for interventional pain medicine physician
1,754
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~369 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hymovis intra-articular injection An injection of Hymovis, a hyaluronan derivative, administered directly into a joint space. |
2,520 | $13 | $100 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,170 | $1 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
658 | $0 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
464 | $110 | $450 |
| Injection, methylprednisolone acetate, 40 mg | 224 | $6 | $20 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
175 | $111 | $430 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
173 | $244 | $980 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
171 | $69 | $295 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
119 | $225 | $1,076 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
119 | $116 | $546 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
110 | $148 | $580 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
84 | $12 | $40 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
80 | $76 | $320 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
78 | $188 | $892 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
63 | $595 | $2,738 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
60 | $334 | $1,181 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
54 | $245 | $990 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
47 | $237 | $1,163 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
47 | $121 | $573 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
42 | $4 | $10 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
41 | $31 | $227 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $101 | $390 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
29 | $52 | $220 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
23 | $520 | $2,359 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
20 | $228 | $910 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
20 | $328 | $1,136 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
19 | $109 | $410 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,656
Total received (2018-2024)
Avg $2,665/year across 7 years
Top 17% in NY for interventional pain medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
1,298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,656 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,633
2023
$3,301
2022
$3,182
2021
$3,434
2020
$1,628
2019
$2,241
2018
$2,238
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$461
Boston Scientific Corporation
$392
SCILEX PHARMACEUTICALS INC.
$255
ABBVIE INC.
$199
Nalu Medical, Inc.
$191
Forte Bio-Pharma LLC
$168
Averitas Pharma Inc.
$153
Azurity Pharmaceuticals, Inc.
$132
DJO, LLC
$114
Medtronic, Inc.
$73
PFIZER INC.
$69
VERTEX PHARMACEUTICALS INCORPORATED
$64
DePuy Synthes Sales Inc.
$49
Curonix LLC
$46
SI-BONE, INC.
$46
Fidia Pharma USA Inc.
$34
PROTEGA PHARMACEUTIALS INC
$27
Saluda Medical Americas, Inc.
$26
Ferring Pharmaceuticals Inc.
$25
Zimmer Biomet Holdings, Inc.
$24
IBSA Pharma Inc.
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Lundbeck LLC
$15
Bioventus LLC
$14
Abbott Laboratories
$14
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$2,039
Abbott Laboratories
$1,772
Boston Scientific Corporation
$1,315
Nevro Corp.
$914
Relievant Medsystems, Inc.
$907
BOSTON SCIENTIFIC CORPORATION
$778
ABBVIE INC.
$760
Medtronic, Inc.
$608
SCILEX PHARMACEUTICALS INC.
$437
BioDelivery Sciences International, Inc.
$432
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$407
Vertos Medical, Inc.
$404
Medtronic USA, Inc.
$386
PFIZER INC.
$380
Nalu Medical, Inc.
$366
Horizon Therapeutics plc
$317
Egalet US Inc
$312
Forte Bio-Pharma LLC
$302
Scilex Pharmaceuticals Inc.
$294
SI-BONE, Inc.
$290
Virtus Pharmaceuticals LLC
$280
Zyla Life Sciences
$277
Daiichi Sankyo Inc.
$276
Averitas Pharma Inc.
$265
Azurity Pharmaceuticals, Inc.
$243
Novartis Pharmaceuticals Corporation
$236
ARBOR PHARMACEUTICALS, INC.
$233
FORTE BIO-PHARMA LLC
$211
Amgen Inc.
$193
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$177
Horizon Pharma plc
$168
DePuy Synthes Sales Inc.
$152
Fidia Pharma USA Inc.
$144
IBSA Pharma Inc.
$139
Kowa Pharmaceuticals America, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$126
RedHill Biopharma Inc.
$121
MML US, Inc.
$118
DJO, LLC
$114
SI-BONE, INC.
$112
Biohaven Pharmaceutical Holding Company Ltd.
$96
Takeda Pharmaceuticals U.S.A., Inc.
$92
Sentynl Therapeutics, Inc.
$91
Arbor Pharmaceuticals, Inc.
$89
AbbVie Inc.
$81
Purdue Pharma L.P.
$81
Assertio Therapeutics, Inc.
$76
AstraZeneca Pharmaceuticals LP
$66
VERTEX PHARMACEUTICALS INCORPORATED
$64
US WorldMeds, LLC
$63
Bioventus LLC
$61
GRT US Holding, Inc.
$51
Stimwave Technologies Incorporated
$50
Shionogi Inc
$49
ASSERTIO THERAPEUTICS, Inc.
$47
Curonix LLC
$46
Allergan Inc.
$46
Almatica Pharma LLC
$38
Inspire Medical Systems, Inc.
$37
Kaleo, Inc.
$30
SANOFI-AVENTIS U.S. LLC
$28
USWM, LLC
$27
PROTEGA PHARMACEUTIALS INC
$27
Saluda Medical Americas, Inc.
$26
Ferring Pharmaceuticals Inc.
$25
Zimmer Biomet Holdings, Inc.
$24
Valinor Pharma, LLC
$22
Baudax Bio Inc.
$19
Zyla Life Sciences, Inc.
$17
Lundbeck LLC
$15
AcelRx Pharmaceuticals, Inc.
$12
FIDIA PHARMA USA INC.
$11
Top 3 companies account for 27.5% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · AIMOVIG · ANJESO · ARTISAN · ARYMO ER · AXIUM · Aimovig · Amitiza · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · CMF · COMIRNATY · DRG IPGs · DSUVIA · DUEXIS · EUFLEXXA · Evekeo · Evoke · Evzio · Flector · GELSYN-3 · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · Gel-One Cross-linked Hyaluronate · General - Pain Management · Gralise · HORIZANT · HYM/HYN · HYMOVIS · Horizant · Hymovis · INSPIRE · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LACTULOSE · LEVORPHANOL TARTRATE · LICART · LUCEMYRA · LYRICA · Levorphanol · Levorphanol Tartrate · Licart · Lucemyra · Lucemyra/Lofexidine · MONOVISC · MOVANTIK · MYSTIM · Morphabond ER · Motegrity · Movantik · NALOCET · NURTEC ODT · Nalu Neurostimulation System · Nucynta · ORTHOVISC · OXAYDO · OXYCONTIN · Octrode SCS Leads · Omnia · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PROLATE · Penta SCS Leads · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · REYVOW · ROXYBOND · ReActiv8 · SEGLENTIS · SPECTRA WAVEWRITER · SPRIX · SYMJEPI · SYMPROIC · SYNCHROMEDII · SYNVISC-ONE · Seglentis · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · Symproic · Tirosint · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · XTAMPZAER · Xtampza ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional pain medicine physicians within 10 mi
23
Per 100K population
1.5
County median income
$128,329
Nearest hospital
BRUNSWICK HOSPITAL CENTER, INC.
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kohane is a mixed practice specialist, with above-average Medicare volume (top 22% in NY), with low-engagement industry engagement in the top 17% of NY peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kohane experienced with hymovis intra-articular injection?
Based on Medicare claims data, Dr. Kohane performed 2,520 hymovis intra-articular injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kohane receive payments from pharmaceutical companies?
Yes. Dr. Kohane received a total of $18,656 from 72 companies across 1,298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kohane's costs compare to other interventional pain medicine physicians in Babylon?
Dr. Kohane's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kohane) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Babylon
Browse interventional pain medicine physicians in Babylon ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in NY
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in NY
Which NY interventional pain medicine physicians receive the most from drug and device companies.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology